Fresh off of the podium at the European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, Arash Mostaghimi MD, MPA, MPH, reviews the latest data on deuruxolitinib (Leqselvi, Sun Pharma) in alopecia areata from EADV and sheds light on where this Janus kinase inhibitor may fit in the alopecia treatment algorithm.
